Your search returned 4 results.

Sort
Results
1.
Reply to a. Avan et Al. MedStar authors:
  • Swain, Sandra M
PMID:
  • 25870094
Year: 2015
Citation:
  • Journal of Clinical Oncology. 33(15):1712, 2015 May 20.
Institution:
  • Washington Cancer Institute
Medline publication type:
  • Comment
  • Letter
Form of publication:
  • Journal Article
All authors:
  • Baselga J, Clark E, Kiermaier A, Swain S
2.
Trastuzumab plus adjuvant chemotherapy for human epidermal growth factor receptor 2-positive breast cancer: planned joint analysis of overall survival from NSABP B-31 and NCCTG N9831. MedStar authors:
  • Swain, Sandra M
PMID:
  • 25332249
Year: 2014
Citation:
  • Journal of Clinical Oncology. 32(33):3744-52, 2014 Nov 20.
Institution:
  • Washington Cancer Institute
Medline publication type:
  • Journal Article
  • Randomized Controlled Trial
  • Research Support, Non-U.S. Gov't
Form of publication:
  • Journal Article
All authors:
  • Colon-Otero G, Davidson NE, Geyer CE Jr, Gralow J, Jeong JH, Mamounas E, Martino S, Perez EA, Rastogi P, Romond EH, Sledge G, Suman VJ, Swain SM, Winer EP, Wolmark N, Zujewski JA
3.
Biomarker analyses in CLEOPATRA: a phase III, placebo-controlled study of pertuzumab in human epidermal growth factor receptor 2-positive, first-line metastatic breast cancer. MedStar authors:
  • Swain, Sandra M
PMID:
  • 25332247
Year: 2014
Citation:
  • Journal of Clinical Oncology. 32(33):3753-61, 2014 Nov 20.
Institution:
  • Washington Cancer Institute
Medline publication type:
  • Clinical Trial, Phase III
  • Journal Article
  • Randomized Controlled Trial
  • Research Support, Non-U.S. Gov't
Form of publication:
  • Journal Article
All authors:
  • Baselga J, Clark E, Cortes J, Im SA, Kiermaier A, Ross G, Swain SM
4.
Anthracyclines in Early Breast Cancer: The ABC Trials-USOR 06-090, NSABP B-46-I/USOR 07132, and NSABP B-49 (NRG Oncology). MedStar authors:
  • Swain, Sandra M
PMID:
  • 28398846
Year: 2017
Citation:
  • Journal of Clinical Oncology. 35(23):2647-2655, 2017 Aug 10.
Institution:
  • Washington Cancer Institute
Medline publication type:
  • Clinical Trial, Phase III
  • Comparative Study
  • Journal Article
  • Randomized Controlled Trial
Form of publication:
  • Journal Article
All authors:
  • Asmar L, Blum JL, Brufsky AM, Colangelo LH, Dang CT, Fehrenbacher L, Flynn PJ, Geyer CE Jr, Gomez HL, Hopkins JO, Jacobs SA, Jeong JH, Jones SE, Lyss AP, Mamounas EP, O'Shaughnessy JA, Paul D, Robert NJ, Swain SM, Vukelja SJ, Wolmark N, Yothers G
Pages

Powered by Koha